Medicine and Dentistry
COVID-19
100%
Child
75%
Infection
70%
Severe Acute Respiratory Syndrome Coronavirus 2
57%
Adeno Associated Virus 2
50%
Pediatrics
34%
Acute Hepatitis
30%
Plasma
30%
Transcriptomics
29%
Antibody Response
28%
Genetic Variability
25%
Neutralizing Antibody
25%
Paraffin
25%
Formaldehyde
25%
Genome Wide Association Study
25%
Meta-Analysis
25%
Tissues
25%
Host Factor
25%
Whole Genome Sequencing
25%
Epigenomics
25%
Immunoglobulin A
25%
Antivirus Agent
25%
Next Generation Sequencing
23%
Association
23%
Liver
21%
Health Care Cost
20%
Hepatitis
19%
Patient
18%
Blood
17%
Human Leukocyte Antigen
15%
Polymerase Chain Reaction
15%
Epidemic
15%
Virus
12%
5 Hydroxymethylcytosine
12%
Human Herpesvirus 6
12%
Serum
12%
Cytokine
12%
Analysis
11%
Protein
11%
Intensive Care Unit
11%
Age Groups
11%
T-Helper Cell
10%
Disease Predisposition
10%
Human Adenovirus C
10%
Virus Genome
9%
Antibody
9%
Vaccine
9%
Epigenetic Modification
8%
Oxygen Therapy
8%
Proteomics
8%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
60%
Host
58%
Adeno Associated Virus 2
50%
Genetics
46%
Sample
40%
DNA
33%
Association
32%
Nested Gene
31%
Transcriptomics
29%
Genetic Architecture
25%
Human Genetics
25%
Immunoprecipitation
25%
Polymerase
25%
Sequencing
25%
Epigenetics
25%
Gene Expression Profiling
25%
Whole Genome Sequencing
25%
Glucose
25%
Glucocorticoid
25%
Reductase
25%
Human Leukocyte Antigen
15%
Protein
14%
T Cell
13%
Genetic Determinism
12%
5-Hydroxymethylcytosine
12%
Human Herpesvirus 6
12%
Mendelian Randomization
11%
Glucocorticoid Receptor
11%
Mineralocorticoid Receptor
11%
Population Dynamics
10%
Genome Wide Association Study
10%
Human Adenovirus C
10%
Virus Genome
9%
Pediatrics
9%
Proteomics
8%
PDE4A
8%
Virus
8%
Experience
6%
RNA Sequencing
6%
Velocity
6%
Smoking
6%
Body Mass
6%
Messenger RNA
6%
Metabolic Pathway
5%
Fat
5%
Allele
5%
Mortality
5%
Learning
5%
MUC1
5%
Membrane
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
58%
COVID-19
56%
Adeno Associated Virus 2
50%
Hepatitis
50%
Cytokine
37%
Virus
31%
Liver
26%
Neutralizing Antibody
25%
Autoantibodies
25%
Brain
25%
Neutralization
25%
Antibody Response
25%
Mutation
25%
Inflammation
25%
Sample
19%
Immunity
15%
Human Leukocyte Antigen
15%
Titer
12%
Mediator
12%
Human Herpesvirus 6
12%
Association
10%
Human Adenovirus C
10%
Virus Genome
9%
Spike
9%
Blood Plasma
9%
Consciousness
8%
Viral Load
8%
Mucosal Immune Response
8%
Allele
8%
Binding Site
6%
Monospecific Antibody
6%
Monoclonal Antibodies
6%
Vaccine Efficacy
6%
Dose
6%
Development
6%
Evolution
6%
Receptor Affinity
6%
in Situ Hybridization
5%
Serology
5%
Coinfection
5%
Helper Virus
5%
Host
5%
Reverse Transcription
5%
